Genome & Company conducts research and development of biological preparations designed to prevent and treat diseases based on the human microbiome. It provides contract development and manufacturing services to numerous R&D firms and sells substances like Toxin, LPS, and Antigens to research institutions, universities, and research material suppliers after production. The company is also engaged in a consumer business selling cosmetics and health supplements utilizing microbiome ingredients.

GNOCLE™ Platform : Genome & Company has established a new drug development platform, GNOCLE™ and effectively conduct research and development in innovative microbiome and novel target based therapeutics. A such unique “Bed-to-Bench” approach using real-world clinical data collected from research institutions and hospitals significantly enhances the success probability of new drug development.

Public

Biotech